Invega Trinza

Paliperidone Palmitate

Paliperidone, sold under the trade name Invega among others, is an atypical antipsychotic. It is mainly used to treat schizophrenia and schizoaffective disorder. It is marketed by Janssen Pharmaceuticals. An extended release formulation is available that uses the OROS extended release system to allow for once-daily dosing. Paliperidone palmitate is a long-acting injectable formulation of paliperidone palmitoyl ester. It is on the World Health Organization's List of Essential Medicines.&#...

NDC Database

Invega Trinza 273 mg/.875ml Intramuscular Injection, Suspension, Extended Release by Janssen Pharmaceuticals, Inc ## Package Codes: 50458-606-01 ## Active Ingredients: Paliperidone Palmitate

NDC Database

Invega Trinza 410 mg/1.315ml Intramuscular Injection, Suspension, Extended Release by Janssen Pharmaceuticals, Inc ## Package Codes: 50458-607-01 ## Active Ingredients: Paliperidone Palmitate

NDC Database

Invega Trinza 546 mg/1.75ml Intramuscular Injection, Suspension, Extended Release by Janssen Pharmaceuticals, Inc ## Package Codes: 50458-608-01 ## Active Ingredients: Paliperidone Palmitate

NDC Database

Invega Trinza 819 mg/2.625ml Intramuscular Injection, Suspension, Extended Release by Janssen Pharmaceuticals, Inc ## Package Codes: 50458-609-01 ## Active Ingredients: Paliperidone Palmitate